ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026

MerTK Inhibition Aggravates Pancreatic Inflammation and Structural Damage via the NF-κB Pathway in an in vivo Type 2 Diabetic Rat Model.

Xiaoyang Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.